Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. Announce Exit from Pharmaceutics International, Inc.
Jabil Inc. (JBL)
Last jabil inc. earnings: 3/13 08:00 am
Check Earnings Report
US:NYSE Investor Relations:
jabil.gcs-web.com/investor-relations
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today announced they have exited their equity stake in Pharmaceutics International, Inc. (“Pii”), a contract development and manufacturing organization, and have closed on an undisclosed all-cash transaction to sell the company to Jabil Inc. (NYSE: JBL), a global leader in engineering, manufacturing, and supply chain solutions.Pii is a contract development and manufacturing business, based in Hunt Valley, Maryland, that specializes in the production of aseptic and sterile injectable pharmaceutical products. The company has been offering development and manufacturing services to pharmaceutical clients, for both NDA and aNDA products, for nearly three decades. Pii has formulation capabilities across virtually all dosage forms and is a sought-after partner for the most complex formulations. The company develops and manufactures dr
Show less
Read more
Impact Snapshot
Event Time:
JBL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JBL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JBL alerts
High impacting Jabil Inc. news events
Weekly update
A roundup of the hottest topics
JBL
News
- Jim Cramer Suggests “I Think You Need to Listen to Jabil Very Closely” [Yahoo! Finance]Yahoo! Finance
- Jabil (NYSE:JBL) had its price target raised by analysts at Bank of America Corporation from $255.00 to $262.00. They now have a "buy" rating on the stock.MarketBeat
- Jabil’s First Quarter of Fiscal Year 2026 Earnings Announcement SetBusiness Wire
- Medical Device Contract Manufacturing Market to Reach USD 191.40 Billion by 2032 Driven by Outsourcing Growth and Innovation in Smart Manufacturing | SNS Insider [Yahoo! Finance]Yahoo! Finance
- Jabil and Inno Invest in New Thailand Facility to Produce Battery Energy Storage System EnclosuresBusiness Wire
JBL
Earnings
- 9/25/25 - Beat
JBL
Sec Filings
- 12/12/25 - Form DEFA14A
- 12/12/25 - Form DEF
- 12/3/25 - Form 4
- JBL's page on the SEC website